Osteopore International Pte Ltd
We are involved in designing, developing and marketing bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery use.
Our proprietary technologies allow for the development of biostructures which are synthetic biologically active tissue engineered products for the restoration of the human skeleton. Industry analyst believes that Osteopore International’s core technology provides multiple opportunities for growth through developing surgical implants and for pursuing rapid regulatory approval for its products to initiate near term revenue opportunities.
Clinical trials for the tissue engineered product, which works by providing a scaffold for the patient’s own bone cells to be regenerated, have been successful. The research team is developing the technology further to enable the scaffold to be implanted in other parts of the body.